Completion Lymph Node Dissection for Melanoma Before and After the Multicenter Selective Lymphadenectomy Trial-II in the United States

SEER Cancer Stat Facts: Melanoma of the Skin. National Cancer Institute. Bethesda, MD. Accessed April 7, 2022. Available at: https://seer.cancer.gov/statfacts/html/melan.html.

Melanoma of the skin. American Cancer Society Cancer Statistics Center. Accessed August 8, 2021. Available at: https://cancerstatisticscenter.cancer.org/#!/cancer-site/Melanoma%20of%20the%20skin.

Rebecca VW, Sondak VK, Smalley KS. A brief history of melanoma: from mummies to mutations. Melanoma Res. 2012;22(2):114–22. https://doi.org/10.1097/CMR.0b013e328351fa4d.

Article  PubMed  PubMed Central  Google Scholar 

Faries MB, Thompson JF, Cochran AJ, et al. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017;376(23):2211–22. https://doi.org/10.1056/NEJMoa1613210.

Article  PubMed  PubMed Central  Google Scholar 

Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17(10):2764–72. https://doi.org/10.1245/s10434-010-1026-z.

Article  PubMed  PubMed Central  Google Scholar 

Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediated thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000;7(2):87–97. https://doi.org/10.1007/s10434-000-0087-9.

Article  CAS  PubMed  Google Scholar 

Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307–17. https://doi.org/10.1056/NEJMoa060992.

Article  CAS  PubMed  Google Scholar 

Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599–609. https://doi.org/10.1056/NEJMoa1310460.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392–9. https://doi.org/10.1001/archsurg.1992.01420040034005.

Article  CAS  PubMed  Google Scholar 

Leiter U, Stadler R, Mauch C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757–67. https://doi.org/10.1016/S1470-2045(16)00141-8.

Article  PubMed  Google Scholar 

Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–20. https://doi.org/10.1258/jrsm.2011.110180.

Article  PubMed  PubMed Central  Google Scholar 

Inkelas M, Brown AF, Vassar SD, et al. Enhancing Dissemination, Implementation, and Improvement Science in CTSAs through Regional Partnerships. Clin Transl Sci. 2015;8(6):800–6. https://doi.org/10.1111/cts.12348.

Article  PubMed  PubMed Central  Google Scholar 

El Sharouni MA, Witkamp AJ, Sigurdsson V, van Diest PJ. Trends in Sentinel Lymph Node Biopsy Enactment for Cutaneous Melanoma. Ann Surg Oncol. 2019;26(5):1494–502. https://doi.org/10.1245/s10434-019-07204-2.

Article  PubMed  PubMed Central  Google Scholar 

Boffa DJ, Rosen JE, Mallin K, et al. Using the National Cancer Database for Outcomes Research: A Review. JAMA Oncol. 2017;3(12):1722–8. https://doi.org/10.1001/jamaoncol.2016.6905.

Article  PubMed  Google Scholar 

About the National Cancer Database. American College of Surgeons, Chicago, IL. Accessed April 7, 2022.

Participant User Files. American College of Surgeons. Accessed April 7, 2022. Available at: https://www.facs.org/quality-programs/cancer-programs/national-cancer-database/puf/.

Broman KK, Richman J, Bhatia S. Evidence and implementation gaps in management of sentinel node-positive melanoma in the United States. Surgery. 2022;172(1):226–33. https://doi.org/10.1016/j.surg.2021.12.025.

Article  PubMed  Google Scholar 

Eggermont AM, Chiarion-Sileni V, Grob JJ, et al. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Lancet Oncol. 2015;16:522–30.

Article  CAS  PubMed  Google Scholar 

Eggermont AM, Chiarion-Sileni V, Grob JJ, et al. Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy [published correction appears in N Engl J Med. 2018;379(22):2185]. N Engl J Med. 2016;375(19):1845-55. doi:https://doi.org/10.1056/NEJMoa1611299.

Weber J, Mandala M, Del Vecchio M, et al. Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma. N Engl J Med. 2017;377(19):1824–35. https://doi.org/10.1056/NEJMoa1709030.

Article  CAS  PubMed  Google Scholar 

Long GV, Hauschild A, Santinami M, et al. Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma. N Engl J Med. 2017;377(19):1813–23. https://doi.org/10.1056/NEJMoa1708539.

Article  CAS  PubMed  Google Scholar 

Eggermont AMM, Blank CU, Mandala M, et al. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. N Engl J Med. 2018;378(19):1789–801. https://doi.org/10.1056/NEJMoa1802357.

Article  CAS  PubMed  Google Scholar 

Hayek SA, Munoz A, Dove JT, et al. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database. Am Surg. 2018;84(5):672–9.

Article  PubMed  Google Scholar 

NIH Policy on the Dissemination of NIH-Funded Clinical Trial Information. National Institutes of Health, U.S. Department of Health and Human Services. Bethesda, MD. Accessed August 23, 2022. Available at: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-149.html.

Luc JGY, Archer MA, Arora RC, et al. Does Tweeting Improve Citations? One-Year Results From the TSSMN Prospective Randomized Trial. Ann Thorac Surg. 2021;111(1):296–300. https://doi.org/10.1016/j.athoracsur.2020.04.065.

Article  PubMed  Google Scholar 

Luc JGY, Archer MA, Arora RC, et al. Social Media Improves Cardiothoracic Surgery Literature Dissemination: Results of a Randomized Trial. Ann Thorac Surg. 2020;109(2):589–95. https://doi.org/10.1016/j.athoracsur.2019.06.062.

Article  PubMed  Google Scholar 

Dyson MP, Newton AS, Shave K, et al. Social Media for the Dissemination of Cochrane Child Health Evidence: Evaluation Study. J Med Internet Res. 2017;19(9):e308. Published 2017 Sep 1. doi:https://doi.org/10.2196/jmir.7819.

Castillo LIR, Hadjistavropoulos T, Brachaniec M. The Effectiveness of Social Media in the Dissemination of Knowledge About Pain in Dementia. Pain Med. 2021;22(11):2584–96. https://doi.org/10.1093/pm/pnab157.

Article  PubMed  PubMed Central  Google Scholar 

Hand RK, Kenne D, Wolfram TM, Abram JK, Fleming M. Assessing the Viability of Social Media for Disseminating Evidence-Based Nutrition Practice Guideline Through Content Analysis of Twitter Messages and Health Professional Interviews: An Observational Study. J Med Internet Res. 2016;18(11):e295. Published 2016 Nov 15. doi:https://doi.org/10.2196/jmir.5811.

Steadman J, Catalani B, Sharp C, Cooper L. Life-threatening perioperative anesthetic complications: major issues surrounding perioperative morbidity and mortality. Trauma Surg Acute Care Open. 2017;2(1):e000113. https://doi.org/10.1136/tsaco-2017-000113.

Article  PubMed  PubMed Central  Google Scholar 

Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006;203(6):865–77. https://doi.org/10.1016/j.jamcollsurg.2006.08.026.

Article  PubMed  Google Scholar 

Hui JYC, Burke E, Broman KK, et al. Surgeon decision-making for management of positive sentinel lymph nodes in the post-Multicenter Selective Lymphadenectomy Trial II era: A survey study. J Surg Oncol. 2021;123(2):646–53. https://doi.org/10.1002/jso.26302.

Article  PubMed  Google Scholar 

Berghe AS, Cobzac G, Dindelegan G, et al. Risk factors for positive sentinel lymph node, lymphatic or hematogenous dissemination over time in patients with cutaneous melanoma. Exp Ther Med. 2021;22(1):730. https://doi.org/10.3892/etm.2021.10162.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif